Quest Diagnostics Inc vs Palantir Technologies Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Palantir Technologies Inc trades at $172.24 (market cap $420.39B). The key difference: Palantir Technologies Inc is far larger — about 16× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Palantir Technologies Inc pays none. Which is the better fit depends on your goals.
| DGX | PLTR | |
|---|---|---|
Market Cap | $26.21B | $420.39B |
Sector | Health | Technology |
52-Week High | $238.50 | $207.18 |
52-Week Low | $173.49 | $107.27 |
Enterprise Value | $31.97B | $411.19B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →